Erlotinib (Tarceva) experience in a public health system, minority patient population with progressive metastatic non-small cell lung cancer (mNSCLC)

被引:0
|
作者
Nathan, Sunita [1 ]
Patel, Pritesh [1 ]
Sharma, Jennifer [1 ]
Samuel, Joyce [1 ]
Stroger, John H., Jr. [1 ]
机构
[1] Cook Cty Hosp, Chicago, IL USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:588S / 589S
页数:2
相关论文
共 50 条
  • [1] Erlotinib (Tarceva) for advanced non-small cell lung cancer
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2005, 47 (1205): : 25 - 26
  • [2] The role of erlotinib (Tarceva, OSI 774) in the treatment of non-small cell lung cancer
    Perez-Soler, R
    CLINICAL CANCER RESEARCH, 2004, 10 (12) : 4238S - 4240S
  • [3] The current situation:: Erlotinib (Tarceva®) and gefitinib (Iressa®) in non-small cell lung cancer
    Comis, RL
    ONCOLOGIST, 2005, 10 (07): : 467 - 470
  • [4] Erlotinib-Induced Cardiomyopathy in a Patient with Metastatic Non-Small Cell Lung Cancer
    Nagashio, Kenji
    Tajiri, Kazuko
    Sato, Kimi
    Ieda, Masaki
    INTERNATIONAL HEART JOURNAL, 2021, 62 (05) : 1171 - 1175
  • [5] Experience with erlotinib in the treatment of non-small cell lung cancer
    Landi, Lorenza
    Cappuzzo, Federico
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2015, 9 (04) : 146 - 163
  • [6] Erlotinib for metastatic non-small cell lung cancer (mNSCLC): First, second or third line setting-Does it matter? A single institution experience
    Ailawadhi, S.
    Derby, L.
    Natrajan, R.
    Reid, M. E.
    Ramnath, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] Experience of nivolumab and pembrolizumab in metastatic non-small cell lung cancer in routine clinical practice (mNSCLC.)
    Ksienski, Doran
    Brooks, Edward Geoffrey
    Fenton, Dave
    Fiorino, Leathia
    Geller, Georgia Samantha
    Poonja, Zia
    Glick, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [8] COGNITIVE CONCERNS AND PERFORMANCE IN PATIENTS WITH METASTATIC NON-SMALL CELL LUNG CANCER (mNSCLC)
    Eggen, Annemarie
    Richard, Nadine
    Shen, Gerald
    Shultz, David
    Leighl, Natasha
    Liu, Geoffrey
    Sun, Alexander
    Bosma, Ingeborg
    Reyners, Anna
    Jalving, Mathilde
    Rodin, Gary
    Edelstein, Kim
    NEURO-ONCOLOGY, 2019, 21 : 159 - 159
  • [9] Tarceva in relapsed non-small cell lung cancer:: experience from Northwest England
    Amir, E.
    Busato, S.
    Koehler, J.
    Lorigan, P.
    Thatcher, N.
    Blackhall, F.
    LUNG CANCER, 2008, 60 : S25 - S26
  • [10] Health and Economic Outcomes of Pembrolizumab in the Treatment of Metastatic Non-small Cell Lung Cancer (mNSCLC) and Melanoma in Italy
    Paoletti, Martina
    Bini, Chiara
    Marcellusi, Andrea
    Mennini, Francesco Saverio
    CLINICAL DRUG INVESTIGATION, 2024, 44 (08) : 601 - 609